{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:26:34Z","timestamp":1789971994457,"version":"4.0.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10585-016-9779-9","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T09:02:43Z","timestamp":1455267763000},"page":"297-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy"],"prefix":"10.1007","volume":"33","author":[{"given":"N. R.","family":"Sluiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M. V.","family":"de Cuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kwakman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. J. H. J.","family":"Meijerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Delis-van Diemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. M. H.","family":"Coup\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A. M.","family":"Beli\u00ebn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. H. J. T.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. A.","family":"te Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"key":"9779_CR1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00308632","volume":"19","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH (1995) Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer. World J Surg 19:235\u2013240. doi: 10.1007\/BF00308632","journal-title":"World J Surg"},{"key":"9779_CR2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000658-199502000-00002","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH, Jablonski KA (1995) Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221:124\u2013132. doi: 10.1097\/00000658-199502000-00003","journal-title":"Ann Surg"},{"key":"9779_CR3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00384-009-0655-9","volume":"24","author":"Y Cao","year":"2009","unstructured":"Cao Y, Tan A, Gao F, Liu L, Liao C, Mo Z (2009) A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer. Int J Colorectal Dis 24:677\u2013685. doi: 10.1007\/s00384-009-0655-9","journal-title":"Int J Colorectal Dis"},{"key":"9779_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, Lorimier G, Dub\u00e8 P, Glehen O (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28:63\u201368. doi: 10.1200\/JCO.2009.23.9285","journal-title":"J Clin Oncol"},{"key":"9779_CR5","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1245\/s10434-013-3145-9","volume":"20","author":"AM Kuijpers","year":"2013","unstructured":"Kuijpers AM, Mirck B, Aalbers AG, Nienhuijs SW, de Hingh IH, Wiezer MJ, van Ramshorst B, van Ginkel RJ, Havenga K, Bremers AJ, de Wilt JH, Te Velde EA, Verwaal VJ, Kuijpers AM, Mirck B, Aalbers AG et al (2013) Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol. Ann Surg Oncol 20:4224\u20134230. doi: 10.1245\/s10434-013-3145-9","journal-title":"Ann Surg Oncol"},{"key":"9779_CR6","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","volume":"21","author":"VJ Verwaal","year":"2003","unstructured":"Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737\u20133743. doi: 10.1200\/JCO.2003.04.187","journal-title":"J Clin Oncol"},{"key":"9779_CR7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jso.21060","volume":"98","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Kusamura S, Baratti D, Deraco M (2008) The eligibility for local-regional treatment of peritoneal surface malignancy. J Surg Oncol 98:220\u2013223. doi: 10.1002\/jso.21060","journal-title":"J Surg Oncol"},{"key":"9779_CR8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ctrv.2012.11.003","volume":"39","author":"EM Cuba de","year":"2013","unstructured":"de Cuba EM, Kwakman R, Knol DL, Bonjer HJ, Meijer GA, Te Velde EA (2013) Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: systematic review of all literature and meta-analysis of observational studies. Cancer Treat Rev 39:321\u2013327. doi: 10.1016\/j.ctrv.2012.11.003","journal-title":"Cancer Treat Rev"},{"key":"9779_CR9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1463-1318.2010.02246.x","volume":"13","author":"L Maggiori","year":"2011","unstructured":"Maggiori L, Bretagnol F, Ferron M, Chevalier Y, Panis Y (2011) Laparoscopic colorectal anastomosis using the novel Chex((R)) circular stapler: a case-control study. Colorectal Dis 13:711\u2013715. doi: 10.1111\/j.1463-1318.2010.02246.x","journal-title":"Colorectal Dis"},{"key":"9779_CR10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejso.2003.12.003","volume":"30","author":"VJ Verwaal","year":"2004","unstructured":"Verwaal VJ, Zoetmulder FA (2004) Follow-up of patients treated by cytoreduction and chemotherapy for peritoneal carcinomatosis of colorectal origin. Eur J Surg Oncol 30:280\u2013285. doi: 10.1016\/j.ejso.2003.12.003","journal-title":"Eur J Surg Oncol"},{"key":"9779_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00428-012-1287-y","volume":"461","author":"EM Cuba de","year":"2012","unstructured":"de Cuba EM, Kwakman R, van Egmond M, Bosch LJ, Bonjer HJ, Meijer GA, te Velde EA (2012) Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers. Virchows Arch 461:231\u2013243. doi: 10.1007\/s00428-012-1287-y","journal-title":"Virchows Arch"},{"key":"9779_CR12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejso.2013.12.021","volume":"40","author":"P Taflampas","year":"2014","unstructured":"Taflampas P, Dayal S, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ (2014) Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei: analysis of 519 patients. Eur J Surg Oncol 40:515\u2013520. doi: 10.1016\/j.ejso.2013.12.021","journal-title":"Eur J Surg Oncol"},{"key":"9779_CR13","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.yexcr.2010.02.045","volume":"316","author":"K Pietras","year":"2010","unstructured":"Pietras K, Ostman A (2010) Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 316:1324\u20131331. doi: 10.1016\/j.ejso.2013.12.021","journal-title":"Exp Cell Res"},{"key":"9779_CR14","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. doi: 10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"9779_CR15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127:679\u2013695. doi: 10.1016\/j.cell.2006.11.001","journal-title":"Cell"},{"key":"9779_CR16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ (2003) The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer 3:453\u2013458. doi: 10.1038\/nrc1098","journal-title":"Nat Rev Cancer"},{"key":"9779_CR17","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1016\/S0021-9258(19)49853-0","volume":"267","author":"J Folkman","year":"1992","unstructured":"Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931\u201310934","journal-title":"J Biol Chem"},{"key":"9779_CR18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1126\/science.1150224","volume":"319","author":"D Gao","year":"2008","unstructured":"Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V (2008) Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319:195\u2013198. doi: 10.1126\/science.1150224","journal-title":"Science"},{"key":"9779_CR19","author":"EMV Cuba de","year":"2016","unstructured":"de Cuba EMV, de Hingh IHJT, Sluiter NR, Kwakman R, Coup\u00e9 VMH, Beli\u00ebn JAM, Verwaal VJ, Meijerink WJHJ, Delis-van Diemen PM, Bonjer HJ, Meijer GA, te Velde EA (2016) Angiogenesis-related markers and prognosis after Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy for metastatic colorectal cancer. Ann Surg Oncol. doi: 10.1245\/s10434-015-5023-0","journal-title":"Ann Surg Oncol"},{"key":"9779_CR20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1245\/s10434-007-9699-7","volume":"15","author":"JM Logan-Collins","year":"2008","unstructured":"Logan-Collins JM, Lowy AM, Robinson-Smith TM, Kumar S, Sussman JJ, James LE, Ahmad SA (2008) VEGF expression predicts survival in patients with peritoneal surface metastases from mucinous adenocarcinoma of the appendix and colon. Ann Surg Oncol 15:738\u2013744. doi: 10.1245\/s10434-007-9699-7","journal-title":"Ann Surg Oncol"},{"key":"9779_CR21","first-page":"701","volume":"28","author":"WW Du","year":"2013","unstructured":"Du WW, Yang W, Yee AJ (2013) Roles of versican in cancer biology\u2013tumorigenesis, progression and metastasis. Histol Histopathol 28:701\u2013713","journal-title":"Histol Histopathol"},{"key":"9779_CR22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00005072-199906000-00004","volume":"58","author":"LC Ang","year":"1999","unstructured":"Ang LC, Zhang Y, Cao L, Yang BL, Young B, Kiani C, Lee V, Allan K, Yang BB (1999) Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain. J Neuropathol Exp Neurol 58:597\u2013605. doi: 10.1079\/00005072-199906000-0004","journal-title":"J Neuropathol Exp Neurol"},{"key":"9779_CR23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2559.2006.02558.x","volume":"49","author":"VT Labropoulou","year":"2006","unstructured":"Labropoulou VT, Theocharis AD, Ravazoula P, Perimenis P, Hjerpe A, Karamanos NK, Kalofonos HP (2006) Versican but not decorin accumulation is related to metastatic potential and neovascularization in testicular germ cell tumours. Histopathology 49:582\u2013593. doi: 10.1111\/j.1365-2559.2006.02558.x","journal-title":"Histopathology"},{"key":"9779_CR24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ygyno.2010.05.029","volume":"119","author":"S Ghosh","year":"2010","unstructured":"Ghosh S, Albitar L, LeBaron R, Welch WR, Samimi G, Birrer MJ, Berkowitz RS, Mok SC (2010) Up-regulation of stromal versican expression in advanced stage serous ovarian cancer. Gynecol Oncol 119:114\u2013120. doi: 10.1016\/j.ygyno.2010.05.029","journal-title":"Gynecol Oncol"},{"key":"9779_CR25","first-page":"1054","volume":"8","author":"C Ricciardelli","year":"2002","unstructured":"Ricciardelli C, Brooks JH, Suwiwat S, Sakko AJ, Mayne K, Raymond WA, Seshadri R, LeBaron RG, Horsfall DJ (2002) Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer. Clin Cancer Res 8:1054\u20131060","journal-title":"Clin Cancer Res"},{"key":"9779_CR26","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1158\/1078-0432.CCR-03-0146","volume":"10","author":"S Suwiwat","year":"2004","unstructured":"Suwiwat S, Ricciardelli C, Tammi R, Tammi M, Auvinen P, Kosma VM, LeBaron RG, Raymond WA, Tilley WD, Horsfall DJ (2004) Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res 10:2491\u20132498. doi: 10.1158\/1078-0432.CCR-03-0146","journal-title":"Clin Cancer Res"},{"key":"9779_CR27","doi-asserted-by":"crossref","first-page":"e13828","DOI":"10.1371\/journal.pone.0013828","volume":"5","author":"WW Du","year":"2010","unstructured":"Du WW, Yang BB, Shatseva TA, Yang BL, Deng Z, Shan SW, Lee DY, Seth A, Yee AJ (2010) Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling. PLoS One 5:e13828. doi: 10.1371\/journal.pone.0013828","journal-title":"PLoS One"},{"key":"9779_CR28","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1074\/jbc.M606991200","volume":"282","author":"C Ricciardelli","year":"2007","unstructured":"Ricciardelli C, Russell DL, Ween MP, Mayne K, Suwiwat S, Byers S, Marshall VR, Tilley WD, Horsfall DJ (2007) Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility. J Biol Chem 282:10814\u201310825. doi: 10.1074\/jbc.M606991200","journal-title":"J Biol Chem"},{"key":"9779_CR29","first-page":"917","volume":"23","author":"T Kusumoto","year":"2010","unstructured":"Kusumoto T, Kodama J, Seki N, Nakamura K, Hongo A, Hiramatsu Y (2010) Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer. Oncol Rep 23:917\u2013925. doi: 10.3892\/or_00000715","journal-title":"Oncol Rep"},{"key":"9779_CR30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1022670501667","volume":"20","author":"RC Casey","year":"2003","unstructured":"Casey RC, Oegema TRJ, Skubitz KM, Pambuccian SE, Grindle SM, Skubitz APN (2003) Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells. Clin Exp Metastasis 20:143\u2013152. doi: 10.1023\/A:1022670501667","journal-title":"Clin Exp Metastasis"},{"key":"9779_CR31","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1111\/j.1525-1438.2006.00660.x","volume":"16","author":"JM Lancaster","year":"2006","unstructured":"Lancaster JM, Dressman HK, Clarke JP, Sayer RA, Martino MA, Cragun JM, Henriott AH, Gray J, Sutphen R, Elahi A, Whitaker RS, West M, Marks JR, Nevins JR, Berchuck A (2006) Identification of genes associated with ovarian cancer metastasis using microarray expression analysis. Int J Gynecol Cancer 16:1733\u20131745. doi: 10.1111\/j.1525-1438.2006.00660.x","journal-title":"Int J Gynecol Cancer"},{"key":"9779_CR32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1369\/0022155411401748","volume":"59","author":"Y Fu","year":"2011","unstructured":"Fu Y, Nagy JA, Brown LF, Shih SC, Johnson PY, Chan CK, Dvorak HF, Wight TN (2011) Proteolytic cleavage of versican and involvement of ADAMTS-1 in VEGF-A\/VPF-induced pathological angiogenesis. J Histochem Cytochem 59:463\u2013473. doi: 10.1369\/0022155411401748","journal-title":"J Histochem Cytochem"},{"key":"9779_CR33","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1096\/fj.03-0545fje","volume":"18","author":"PS Zheng","year":"2004","unstructured":"Zheng PS, Wen J, Ang LC, Sheng W, Viloria-Petit A, Wang Y, Wu Y, Kerbel RS, Yang BB (2004) Versican\/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J 18:754\u2013756. doi: 10.1096\/fj.03-0545fje","journal-title":"FASEB J"},{"key":"9779_CR34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10434-004-1167-z","volume":"12","author":"VJ Verwaal","year":"2005","unstructured":"Verwaal VJ, van Ruth S, Witkamp A, Boot H, van Slooten G, Zoetmulder FA (2005) Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 12:65\u201371. doi: 10.1007\/s10434-004-1167-z","journal-title":"Ann Surg Oncol"},{"key":"9779_CR35","doi-asserted-by":"crossref","first-page":"168.e1-9","DOI":"10.1016\/j.ajog.2013.10.881","volume":"210","author":"MH Kerkhof","year":"2014","unstructured":"Kerkhof MH, Ruiz-Zapata AM, Bril H, Bleeker MC, Belien JA, Stoop R, Helder MN (2014) Changes in tissue composition of the vaginal wall of prementopausal women with prolapse. Am J Obstet Gynecol 210:168.e1-9. doi: 10.1016\/j.ajog.2013.10.881","journal-title":"Am J Obstet Gynecol"},{"key":"9779_CR36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/biomet\/57.3.579","volume":"57","author":"N Breslow","year":"1970","unstructured":"Breslow N (1970) A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 57:579\u2013594. doi: 10.1093\/biomet\/57.3.579","journal-title":"Biometrika"},{"issue":"Suppl 3","key":"9779_CR37","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1245\/s10434-012-2441-0","volume":"20","author":"M Wit de","year":"2013","unstructured":"de Wit M, Belt EJ, Delis-van Diemen PM, Carvalho B, Coup\u00e9 VM, Stockmann HB, Bril H, Beli\u00ebn JA, Fijneman RJ, Meijer GA (2013) Lumican and versican are associated with good outcome in stage II and III colon cancer. Ann Surg Oncol 20(Suppl 3):S348\u2013S359. doi: 10.1245\/s10434-012-2441-0","journal-title":"Ann Surg Oncol"},{"key":"9779_CR38","doi-asserted-by":"crossref","first-page":"31954","DOI":"10.1074\/jbc.M702099200","volume":"282","author":"JT Read","year":"2007","unstructured":"Read JT, Rahmani M, Boroomand S, Allahverdian S, McManus BM, Rennie PS (2007) Androgen receptor regulation of the versican gene through an androgen response element in the proximal promoter. J Biol Chem 282:31954\u201331963. doi: 10.1074\/jbc.M702099200","journal-title":"J Biol Chem"},{"issue":"4","key":"9779_CR39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jso.21068","volume":"98","author":"AG Portilla","year":"2008","unstructured":"Portilla AG, Shigeki K, Dario B, Marcello D (2008) The intraoperative staging systems in the management of peritoneal surface malignancy. J Surg Oncol 98(4):228\u2013231. doi: 10.1002\/jso.21068","journal-title":"J Surg Oncol"},{"issue":"1","key":"9779_CR40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00428-012-1252-9","volume":"461","author":"E Williams","year":"2012","unstructured":"Williams E, Martin S, Moss R, Durrant L, Deen S (2012) Co-expression of VEGF and CA9 in ovarian high-grade serous carcinoma and relationship to survival. Virchows Arch 461(1):33\u201339","journal-title":"Virchows Arch"},{"issue":"4","key":"9779_CR41","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1054\/bjoc.2001.1936","volume":"85","author":"RM Shaheen","year":"2001","unstructured":"Shaheen RM, Ahmad SA, Liu W, Reinmuth N, Jung YD, Tseng WW et al (2001) Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Br J Cancer 85(4):584\u2013589. doi: 10.1054\/bjoc.2001.1936","journal-title":"Br J Cancer"},{"issue":"9","key":"9779_CR42","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00595-009-4154-y","volume":"40","author":"T Imaizumi","year":"2010","unstructured":"Imaizumi T, Aoyagi K, Miyagi M, Shirouzu K (2010) Suppressive effect of bevacizumab on peritoneal dissemination from gastric cancer in a peritoneal metastasis model. Surg Today 40(9):851\u2013857","journal-title":"Surg Today"},{"issue":"6","key":"9779_CR43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000279385","volume":"77","author":"Y Bai","year":"2009","unstructured":"Bai Y, Deng H, Yang Y, Zhao X, Wei Y, Xie G et al (2009) VEGF-targeted short hairpin RNA inhibits intraperitoneal ovarian cancer growth in nude mice. Oncology 77(6):385\u2013394. doi: 10.1159\/000279385","journal-title":"Oncology"},{"issue":"2","key":"9779_CR44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijgo.2009.11.021","volume":"109","author":"SM Diniz Bizzo","year":"2010","unstructured":"Diniz Bizzo SM, Meira DD, Lima JM, Moror\u00f3 JDS, Casali-da-Rocha JC, Ornellas MHF (2010) Peritoneal VEGF burden as a predictor of cytoreductive surgery outcome in women with epithelial ovarian cancer. Int J Gynaecol Obstet 109(2):113\u2013117. doi: 10.1016\/j.ijgo.2009.11.021","journal-title":"Int J Gynaecol Obstet"},{"issue":"12","key":"9779_CR45","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1245\/s10434-007-9557-7","volume":"14","author":"S Varghese","year":"2007","unstructured":"Varghese S, Burness M, Xu H, Beresnev T, Pingpank J, Alexander HR (2007) Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum. Ann Surg Oncol 14(12):3460\u20133471. doi: 10.1245\/s10434-007-9557-7","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"9779_CR46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10434-999-0373-0","volume":"6","author":"BK Zebrowski","year":"1999","unstructured":"Zebrowski BK, Liu W, Ramirez K, Akagi Y, Mills GB, Ellis LM (1999) Markedly elevated levels of vascular endothelial growth factor in malignant ascites. Ann Surg Oncol 6(4):373\u2013378. doi: 10.1007\/s10434-999-0373-0","journal-title":"Ann Surg Oncol"},{"issue":"5B","key":"9779_CR47","first-page":"3849","volume":"26","author":"T Yoshikawa","year":"2006","unstructured":"Yoshikawa T, Tsuburaya A, Miyagi Y, Sekiguchi H, Kimura M, Cho H, Kobayashi O (2006) Up-regulation of hypoxia-inducible factor-1 alpha and VEGF mRNAs in peritoneal dissemination of patients with gastric cancer. Anticancer Res 26(5B):3849\u20133853","journal-title":"Anticancer Res"},{"issue":"5","key":"9779_CR48","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2353\/ajpath.2006.051222","volume":"169","author":"SA Gerber","year":"2006","unstructured":"Gerber SA, Rybalko VY, Bigelow CE, Lugade AA, Foster TH, Frelinger JG, Lord EM (2006) Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. Am J Pathol 169(5):1739\u20131752. doi: 10.2353\/ajpath.2006.051222","journal-title":"Am J Pathol"},{"issue":"12","key":"9779_CR49","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1634\/theoncologist.2009-0109","volume":"14","author":"S Kobold","year":"2009","unstructured":"Kobold S, Hegewisch-Becker S, Oechsle K, Jordan K, Bokemeyer C, Atanackovic D (2009) Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites? Oncologist 14(12):1242\u20131251. doi: 10.1634\/theoncologist.2009-0109","journal-title":"Oncologist"},{"issue":"2","key":"9779_CR50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jss.2008.08.017","volume":"154","author":"S Ninomiya","year":"2009","unstructured":"Ninomiya S, Inomata M, Tajima M, Ali AT, Ueda Y, Shiraishi N, Kitano S (2009) Effect of bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor, on peritoneal metastasis of MNK-45P human gastric cancer in mice. J Surg Res 154(2):196\u2013202. doi: 10.1016\/j.jss.2008.08.017","journal-title":"J Surg Res"},{"key":"9779_CR51","first-page":"221","volume":"18","author":"RM Shaheen","year":"2001","unstructured":"Shaheen RM, Tseng WW, Vellagas R, Liu W, Ahmad SA, Jung YD, Reinmuth N, Drazan KE, Bucana CD, Hicklin DJ, Ellis LM (2001) Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis. Int J Oncol 18:221\u2013226","journal-title":"Int J Oncol"},{"issue":"2","key":"9779_CR52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/COC.0b013e3182438c55","volume":"36","author":"YLB Klaver","year":"2013","unstructured":"Klaver YLB, Leenders BJM, Creemers G-J, Rutten HJT, Verwaal VJ, Lemmens VEPP et al (2013) Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin. Am J Clin Oncol 36(2):157\u2013161. doi: 10.3892\/ijo.18.2.221","journal-title":"Am J Clin Oncol"},{"key":"9779_CR53","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1245\/s10434-014-3713-7","volume":"21","author":"W Ceelen","year":"2014","unstructured":"Ceelen W, Van NY, Putte DV, Pattyn P (2014) Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis. Ann Surg Oncol 21:3023\u20133028. doi: 10.1245\/s10434-014-3713-7","journal-title":"Ann Surg Oncol"},{"key":"9779_CR54","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1245\/s10434-013-3442-3","volume":"21","author":"C Eveno","year":"2014","unstructured":"Eveno C, Passot G, Go\u00e9r\u00e9 D, Soyer P, Gayat E, Glehen O, Elias D, Pocard M (2014) Bevacizumab doubles the early postoperative complication rate after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 21:1792\u20131800. doi: 10.1245\/s10434-013-3442-3","journal-title":"Ann Surg Oncol"},{"key":"9779_CR55","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1111\/j.1742-4658.2010.07800.x","volume":"277","author":"AD Theocharis","year":"2010","unstructured":"Theocharis AD, Skandalis SS, Tzanakakis GN, Karamanos NK (2010) Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J 277:3904\u20133923. doi: 10.1111\/j.1742-4658.2010.07800.x","journal-title":"FEBS J"},{"key":"9779_CR56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jcp.20921","volume":"211","author":"W Sheng","year":"2007","unstructured":"Sheng W, Dong H, Lee DY, Lu WY, Yang BB (2007) Versican modulates gap junction intercellular communication. J Cell Physiol 211:213\u2013219. doi: 10.1002\/jcp.20921","journal-title":"J Cell Physiol"},{"key":"9779_CR57","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1096\/fj.03-0660fje","volume":"18","author":"S Cattaruzza","year":"2004","unstructured":"Cattaruzza S, Schiappacassi M, Kimata K, Colombatti A, Perris R (2004) The globular domains of PG-M\/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells. FASEB J 18:779\u2013781. doi: 10.1096\/fj.03-0660fje","journal-title":"FASEB J"},{"key":"9779_CR58","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/1471-2407-12-341","volume":"12","author":"WW Du","year":"2012","unstructured":"Du WW, Fang L, Yang W, Sheng W, Zhang Y, Seth A, Yang BB, Yee AJ (2012) The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro\u2014evaluation towards understanding breast cancer cell bone metastasis. BMC Cancer 12:341. doi: 10.1186\/1471-2407-12-341","journal-title":"BMC Cancer"},{"key":"9779_CR59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.matbio.2004.11.007","volume":"24","author":"Y Wu","year":"2005","unstructured":"Wu Y, Wu J, Lee DY, Yee A, Cao L, Zhang Y, Kiani C, Yang BB (2005) Versican protects cells from oxidative stress-induced apoptosis. Matrix Biol 24:3\u201313. doi: 10.1016\/j.matbio.2004.11.007","journal-title":"Matrix Biol"},{"key":"9779_CR60","doi-asserted-by":"crossref","first-page":"12294","DOI":"10.1074\/jbc.M110748200","volume":"277","author":"Y Wu","year":"2002","unstructured":"Wu Y, Chen L, Zheng PS, Yang BB (2002) beta 1-Integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M\/versican. J Biol Chem 277:12294\u201312301. doi: 10.1074\/jbc.M110748200","journal-title":"J Biol Chem"},{"key":"9779_CR61","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1158\/0008-5472.CAN-06-3610","volume":"67","author":"DP LaPierre","year":"2007","unstructured":"LaPierre DP, Lee DY, Li SZ, Xie YZ, Zhong L, Sheng W, Deng Z, Yang BB (2007) The ability of versican to simultaneously cause apoptotic resistance and sensitivity. Cancer Res 67:4742\u20134750. doi: 10.1158\/0008-5472.CAN-06-3610","journal-title":"Cancer Res"},{"key":"9779_CR62","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature11183","volume":"487","author":"R Straussman","year":"2012","unstructured":"Straussman R, Morikawa T, Shee K, Barzily-Rokni M, Qian ZR, Du J, Davis A, Mongare MM, Gould J, Frederick DT, Cooper ZA, Chapman PB, Solit DB, Ribas A, Lo RS, Flaherty KT, Ogino S, Wargo JA, Golub TR (2012) Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 487:500\u2013504. doi: 10.1038\/nature11183","journal-title":"Nature"},{"key":"9779_CR63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10585-010-9363-7","volume":"28","author":"MP Ween","year":"2011","unstructured":"Ween MP, Hummitzsch K, Rodgers RJ, Oehler MK, Ricciardelli C (2011) Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides. Clin Exp Metastasis 28:113\u2013125. doi: 10.1007\/s10585-010-9363-7","journal-title":"Clin Exp Metastasis"},{"key":"9779_CR64","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/bcr1751","volume":"9","author":"AJ Yee","year":"2007","unstructured":"Yee AJ, Akens M, Yang BL, Finkelstein J, Zheng PS, Deng Z, Yang B (2007) The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Breast Cancer Res 9:R47. doi: 10.1186\/bcr1751","journal-title":"Breast Cancer Res"},{"key":"9779_CR65","first-page":"1041","volume":"5","author":"LF Brown","year":"1999","unstructured":"Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF (1999) Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 5:1041\u20131056","journal-title":"Clin Cancer Res"},{"issue":"12","key":"9779_CR66","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/jnci\/94.12.883","volume":"94","author":"L Hlatky","year":"2002","unstructured":"Hlatky L, Hahnfeldt P, Folkman J (2002) Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn\u2019t tell us. J Natl Cancer Inst 94(12):883\u2013893. doi: 10.1093\/jnci\/94.12.883","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"9779_CR67","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3858\/emm.2009.41.12.103","volume":"41","author":"L Chen","year":"2009","unstructured":"Chen L, Endler A, Shibasaki F (2009) Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors. Exp Mol Med 41(12):849\u2013857. doi: 10.3858\/emm.2009.41.12.103","journal-title":"Exp Mol Med"},{"key":"9779_CR68","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ijc.11423","volume":"107","author":"K Voutilainen","year":"2003","unstructured":"Voutilainen K, Anttila M, Sillanp\u00e4\u00e4 S, Tammi R, Tammi M, Saarikoski S, Kosma VM (2003) Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis. Int J Cancer 107:359\u2013364. doi: 10.1002\/ijc.11423","journal-title":"Int J Cancer"},{"issue":"5","key":"9779_CR69","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/bjc.2015.18","volume":"112","author":"R Kwakman","year":"2015","unstructured":"Kwakman R, de Cuba EM, de Winter JP, de Hingh IH, Delis-van Diemen PM, Tijssen M, Rooimans MA, Krijgsman O, Carvalho B, Peters GJ, Bonjer HJ, Meijer GA, Te Velde EA (2015) Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival. Br J Cancer 112(5):851\u2013856. doi: 10.1038\/bjc.2015.18","journal-title":"Br J Cancer"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-016-9779-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-016-9779-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-016-9779-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:35:54Z","timestamp":1654302954000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-016-9779-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["9779"],"URL":"https:\/\/doi.org\/10.1007\/s10585-016-9779-9","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]}}}